Morinaga Milk国际B2B业务部总经理Yoshihiko Ushida博士表示:“我们的益生菌株B. breve B-3因减少体内脂肪的临床功效而获得了韩国单独认可注册的批准,对此我们感到非常激动和自豪。”他补充道:“近年来,韩国的益生菌市场增长强劲,并将进一步增长。此次批准高度认可了B. breve B-3的质量和安全性,以及其经过科学验证...
已经报道了由双歧杆菌引起的几种类型的感染。偶尔的感染发现还包括B. scardovii。 在一项研究中,从无菌场所分离出的 15 种推定的双歧杆菌分离株或大量存在的双歧杆菌被鉴定到物种水平,鉴定出四种:A. omnicolens、B. breve、B. longum、B. scardovii,来自胃肠道或泌尿生殖道,B. breve来自血液。Scardovia wiggs...
Some strains of B. breve have been shown to be effective at relieving intestinal inflammation, but the modes of action have yet to be elucidated. In this study, we investigated the mechanisms of action of B. breve CBT BR3 isolated from South Korean infant feces in relieving colitis in ...
B. breve,B. bifidum,B. adolescentisandB. pseudocatenulatum. Animal derived species includeB. pseudolongum,Bifidobacterium thermophilusandB. animalis. Some animal species are host specific such asB. magnumandB. cuniculiwhich have only been found in rabbit faecal samples,B. pullorumandB. gallinarumi...
A double-blind randomized, placebo-control trial in 49 children who have celiac disease found a reduction in TNF-α levels, a pro-inflammatory cytokine, after consuming B. breve for 3 months but the findings were reversed after intervention had ceased (Klemenak et al., 2015). A more recent...
In this study, we demonstrate that the prototype B. breve strain UCC2003 possesses specific metabolic pathways for the utilisation of lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT), which represent the central moieties of Type I and Type II human
On March 7, 2023, the probiotic strainB. breveB-3 received the approval of Individual Recognized Registration (No. 2023-2) by the Minister of Food and Drug Safety of South Korea. The probiotic strain meets the highest standards of safety, functionality, and regulatory compliance and can be ...
59. Multiple studies by Sagaret al. demonstrated thatB.breveM-16 V has strong anti-inflammatory properties and was capable of suppressing pulmonary airway inflammation and airway remodelling in a model of chronic allergic asthma41,42. Additionally,B.brevestrains are capable of directing DCs and ...
B.breve、B.adolescent、B.longumsubsp.longum几乎不能直接利用XOS生长,这种菌株利用XOS能力的差异可能与糖苷酶有关。实验组中B.longumsubsp.infantisJNFE3在24 h时的OD600 nm为0.517,对照组B.infantisJNFE3在24 h时的OD600 nm为2.417,是实...
B. bifidum, B. breve, B. infantisBifidum-multi-1 (Russia) capsules B. bifidum, B. breve, B. infantis, B. longumBifidum-multi-2 (Russia) capsules B. bifidum, L. acidophilusInfloran Bern (Switzerland) capsules B. longum, L. acidophilusOmniflora (Germany) capsules ...